Complete financial analysis of Zentek Ltd. (ZEN.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zentek Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- KLEA HOLDING (ALKLH.PA) Income Statement Analysis – Financial Results
- Ten Sixty Four Limited (X64.AX) Income Statement Analysis – Financial Results
- We-R-You Corp. (WERU) Income Statement Analysis – Financial Results
- Honyaku Center Inc. (2483.T) Income Statement Analysis – Financial Results
- Galway Metals Inc. (GAYMF) Income Statement Analysis – Financial Results
Zentek Ltd. (ZEN.V)
About Zentek Ltd.
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.82K | 72.86K | 339.67K | 2.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 414.88K | 853.34K | 614.71K | 126.80K | 24.88K | 5.30K | 6.07K | 9.71K | 11.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -385.06K | -780.48K | -275.04K | -124.44K | -24.88K | -5.30K | -6.07K | -9.71K | -11.38K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -1,291.45% | -1,071.28% | -80.97% | -5,284.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.78M | 1.65M | 1.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 8.57M | 10.62M | 10.25M | 4.20M | 1.65M | 2.46M | 1.63M | 2.82M | 4.16M | 3.01M | 3.43M | 2.58M | 1.70M | 1.54M | 153.54K |
| Selling & Marketing | 375.55K | 307.92K | 280.74K | 70.41K | 92.02K | 69.46K | 0.00 | 11.72K | 30.73K | 33.95K | 119.78K | 115.67K | 0.00 | 0.00 | 0.00 |
| SG&A | 8.95M | 10.93M | 10.25M | 4.20M | 1.65M | 2.46M | 1.63M | 2.84M | 4.19M | 3.04M | 3.55M | 2.69M | 1.70M | 1.54M | 153.54K |
| Other Expenses | -31.86K | -2.02K | 1.88K | 109.80K | -66.02K | 23.89K | 6.07K | 9.71K | 11.38K | 13.68K | 16.28K | 16.75K | 18.78K | 6.49K | 0.00 |
| Operating Expenses | -301.26K | 14.73M | 12.32M | 3.98M | 1.59M | 2.47M | 1.64M | 2.85M | 4.20M | 3.06M | 3.56M | 2.71M | 1.71M | 1.55M | 153.54K |
| Cost & Expenses | 11.02M | 14.73M | 12.32M | 3.98M | 1.59M | 2.47M | 1.64M | 2.85M | 4.20M | 3.06M | 3.56M | 2.71M | 1.71M | 1.55M | 153.54K |
| Interest Income | 405.48K | 510.26K | 20.60K | 6.46K | 6.53K | 16.41K | 75.31K | 5.53K | 4.07K | 40.67K | 43.13K | 19.47K | 51.39K | 25.84K | 184.00 |
| Interest Expense | 112.07K | 120.62K | 63.78K | 12.81K | 0.00 | 16.41K | 75.31K | 5.53K | 4.07K | 40.67K | 5.24K | 19.47K | 51.39K | 25.84K | 184.00 |
| Depreciation & Amortization | 613.71K | 539.69K | 614.71K | 126.80K | 24.88K | 5.30K | 6.07K | 9.71K | 11.38K | 13.68K | 16.28K | 16.75K | 18.78K | 6.49K | 0.00 |
| EBITDA | -11.08M | -13.75M | -11.27M | -3.73M | -1.55M | -2.42M | -1.60M | -2.83M | -4.19M | -3.00M | -3.51M | -2.67M | -1.64M | -1.51M | -153.35K |
| EBITDA Ratio | -37,154.53% | -18,680.73% | -3,339.64% | -163,826.24% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -10.99M | -14.15M | -12.56M | -3.98M | -1.68M | -2.47M | -1.64M | -2.85M | -4.20M | -3.06M | -3.57M | -2.71M | -1.71M | -1.55M | -153.54K |
| Operating Income Ratio | -36,850.03% | -19,421.50% | -3,698.53% | -169,210.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -816.57K | -264.73K | 540.55K | 116.26K | 12.08K | 40.30K | 75.31K | 5.53K | 4.07K | 40.67K | 43.13K | 19.47K | 51.39K | 25.84K | 184.00 |
| Income Before Tax | -11.80M | -14.41M | -12.02M | -3.87M | -1.54M | -2.43M | -1.56M | -2.84M | -4.20M | -3.02M | -3.52M | -2.69M | -1.66M | -1.52M | -153.35K |
| Income Before Tax Ratio | -39,588.72% | -19,784.87% | -3,539.39% | -164,273.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -99.78K | 118.61K | 26.74M | -6.46K | -6.53K | 56.72K | 0.00 | 0.00 | 0.00 | 0.00 | 48.37K | -339.30K | -623.12K | -277.70K | -5.40K |
| Net Income | -11.70M | -14.41M | -38.69M | -3.87M | -1.53M | -2.43M | -1.56M | -2.84M | -4.20M | -3.02M | -3.52M | -2.35M | -1.04M | -1.24M | -147.95K |
| Net Income Ratio | -39,254.06% | -19,784.87% | -11,391.79% | -164,273.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.12 | -0.14 | -0.42 | -0.05 | -0.02 | -0.04 | -0.02 | -0.05 | -0.07 | -0.05 | -0.06 | -0.06 | -0.03 | -0.05 | -0.06 |
| EPS Diluted | -0.12 | -0.14 | -0.42 | -0.05 | -0.02 | -0.04 | -0.02 | -0.05 | -0.07 | -0.05 | -0.06 | -0.06 | -0.03 | -0.05 | -0.06 |
| Weighted Avg Shares Out | 97.53M | 99.44M | 92.09M | 84.02M | 76.86M | 67.30M | 63.09M | 62.13M | 58.21M | 55.86M | 54.40M | 39.20M | 39.63M | 27.53M | 2.41M |
| Weighted Avg Shares Out (Dil) | 100.50M | 99.44M | 92.09M | 84.02M | 76.86M | 67.30M | 63.09M | 62.13M | 58.21M | 55.95M | 54.48M | 41.13M | 39.63M | 27.53M | 2.41M |
Source: https://incomestatements.info
Category: Stock Reports